Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Burden of Cardiovascular Disease in Hsct Publisher



Emami AH1 ; Alizadehasl A2 ; Bezanjani FN2 ; Hajiali H2
Authors

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024


Abstract

Cancers Cancer inflict the largest burden in the world. Burden of Cancer incidence and mortality is also growing. Hematopoietic stem cell transplantatio Hematopoietic Stem Cell Transplantation (HSCT) (HSCT) is a curative therapeutic method for malignant hematologic disorders and is associated with early and late treatment related mortality. Cardiac toxicity and cardiovascular consequences are not common in post HSCT patients compared to other HSCT Hematopoietic Stem Cell Transplantation (HSCT) related complications. However, these complications play an important role in survivors' outcome. It is necessary to identify and decrease these life-threatening complications to improve patients' outcome and decline related cost burden. © Springer Nature Switzerland AG 2024. All rights reserved.
Related Docs
View other Related Docs
1. Long Term Cardiotoxicity Surveillance in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
2. Pre-Hsct Cardiovascular Evaluation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Risk Factors and Mechanisms of Cardiotoxicity in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
Experts (# of related papers)
View all Related Experts
Mohammad Vaezi (3)
Ghasem Janbabaei (3)
Other Related Docs
4. Cardiovascular Diseases in Patients After Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis, Current Research in Translational Medicine (2023)
5. Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
6. Pericardial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
7. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
8. Late Complications in Acute Leukemia Patients Following Hsct: A Single Center Experience, International Journal of Hematology-Oncology and Stem Cell Research (2016)
9. Hematopoietic Stem Cell Transplantation and Lymphodepletion for the Treatment of Cancer, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
10. Rehabilitation in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
11. Optimizing Peripheral Blood Stem Cells Transplantation Outcome Through Amend Relapse and Graft Failure: A Review of Current Literature, Experimental Hematology and Oncology (2017)
12. Hsct at a Glance, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
13. Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review, International Journal of Hematology-Oncology and Stem Cell Research (2025)
14. Fear of Cancer Recurrence and Coping Strategies Among Prostate Cancer Survivors: A Qualitative Study, Current Oncology (2023)
15. Radiation-Free Reduced-Intensity Hematopoietic Stem Cell Transplantation With in Vivo T-Cell Depletion From Matched Related and Unrelated Donors for Fanconi Anemia: Prognostic Factor Analysis, Experimental Hematology (2022)
16. Shedding Light on the Side Effects of Immunotherapies Used for Leukemia: An Updated Review of the Literature, Expert Review of Anticancer Therapy (2023)
17. Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region (Emro) 2011-2012: A Comprehensive Report on Behalf of the Eastern Mediterranean Blood and Marrow Transplantation Group (Embmt), Hematology/ Oncology and Stem Cell Therapy (2015)
18. Physical Therapy Pathway and Protocol for Patients Undergoing Hematopoietic Stem Cell Transplantation: Recommendations From the Eastern Mediterranean Blood and Marrow Transplantation (Embmt) Group, Hematology/ Oncology and Stem Cell Therapy (2019)
19. Advances in Hematopoietic Stem Cell Transplantation in the Asia-Pacific Region: The Second Report From Apbmt 2005–2015, Bone Marrow Transplantation (2019)
20. Outcome of Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation As a Treatment Option in Patients With Severe Aplastic Anemia Between 40 and 50 Years, Hematology/ Oncology and Stem Cell Therapy (2022)